May 16, 2026 · 1h 8m · 20vc

The Five Year Desert to Product Market Fit & a $5.3BN Valuation with Shiv Rao, Founder @ Abridge · 20VC with Harry Stebbings

Shiv Rao · 48m spoken Harry Stebbings · 13m spoken
0:00 / 0:00
▶ Watch on YouTube →

gold bands on the timeline = statements, start to end. Hover to read, click to jump. CC turns on captions

In this in-depth interview, Abridge founder and CEO Shiv Rao discusses the company's journey to a $5.3 billion valuation, detailing the strategic pivots, fundraising challenges, technical choices, and wartime leadership principles that allowed them to scale a leading healthcare AI assistant.

How this conversation actually went

Every chapter scored 0–10 on four independent dynamics. Hover any point for the reasoning behind the score. Harry holds 21.8% of the talking time here. How this is scored →

Harry as informed peer 4.0 Guest teaching 3.0 Guest disagreement 1.4 Harry pushing back 2.8
05100:0015:0030:0045:001:00:001:09–3:31 · Harry as informed peer 2/10 Meeting and Early Impressions Harry opens with warm praise and an engaging binary question on founder motivation before asking about market timing lessons. Shiv responds collaboratively, reflecting on maintaining thesis resilience during Abridge's early wilderness period.3:31–6:42 · Harry as informed peer 3/10 Dying on the Hill: Unwavering Commitment to the Core Thesis Harry challenges whether Shiv would have died on his thesis if the market hadn't caught up, pressing on early fundraising difficulties. Shiv articulates how he pivoted tactics while holding firm to his core thesis on healthcare conversations.6:42–9:45 · Harry as informed peer 2/10 The Differentiator of Taste in the Era of AI Harry brings up taste as a human differentiator in AI, asking Shiv to reflect on company values and strong opinions loosely held. Shiv explains living at the edge of culture and updating priors as company scope expands.9:45–13:36 · Harry as informed peer 4/10 Ambition and the Impossibility of Founder Satisfaction Harry uses his experience as an investor in Legora to frame questions about market adoption and GTM traps in enterprise healthcare. Shiv educates Harry on the fragmented $5.3T healthcare market structure and timing the move upmarket.13:36–17:39 · Harry as informed peer 5/10 The Timing of Being First and the Three Eras of AI-Native Companies Harry asks how vertical AI companies survive foundation models building healthcare apps. Shiv responds forcefully that fighting foundation models is a losing battle and outlines Abridge's deep workflow integration and mid/post-training strategy.17:39–19:44 · Harry as informed peer 5/10 Proprietary Models vs. Riding the Frontier Model Wave Harry pushes back on the decision to build in-house models given historical precedents like Cursor and fast-moving foundation models. Shiv explains that in-house models are necessary to optimize latency, cost, and workflow speed for doctors.19:44–23:53 · Harry as informed peer 4/10 Optimizing for Milliseconds and User Experience Harry challenges Shiv on when cost consciousness becomes essential for funded startups, bringing up IPO timing. Shiv recounts a conversation with Henry Kravis to explain why serving the mission in private markets takes precedence over premature optimization.23:53–27:09 · Harry as informed peer 4/10 Data Cleanliness, Deployment Complexities, and the FDE Process Harry questions whether an FDE model is mandatory for selling AI into enterprise healthcare. Shiv details how Abridge picked a universal spoken wedge (doctor-patient notes) to scale without needing massive forward deployment teams.27:09–30:29 · Harry as informed peer 5/10 Moving Closer to the Flow of Money and Threading the Stakeholder Needle Harry pushes Shiv with feedback from an anonymous investor regarding moving closer to money flows, and asks how they compete with entrenched players like Epic. Shiv reframes Epic as a partner EMR while Abridge operates as the intelligence layer.30:29–33:21 · Harry as informed peer 4/10 Reflecting on Missteps: The Pivot from Patient-Facing to Enterprise Harry directly probes whether building a consumer-facing app during the pandemic was a strategic mistake. Shiv acknowledges spending too many cycles on DTC monetization before shifting focus to enterprise healthcare revenue.33:21–36:17 · Harry as informed peer 4/10 Pricing Models and Competing with Microsoft Nuance Harry asks how Abridge handles pricing mechanics against CFO expectations and bundling threats from Microsoft Nuance. Shiv describes counter-positioning against Microsoft's complex pricing structures and building category dominance.36:17–39:42 · Harry as informed peer 5/10 Focus, Counter-Positioning, and Competing with Giants Harry presents a strong counterargument, asking if withholding healthcare data from frontier models like OpenAI is actually immoral given potential public health benefits. Shiv counters that trust and explicit health-system alignment are prerequisite to long-term impact.39:42–43:12 · Harry as informed peer 5/10 Talent Acquisition: Prioritizing People Over Early Model Access Harry provocatively suggests that if AI is giving doctors prompts and diagnoses, AI should just replace them. Shiv firmly pushes back, explaining the sheer volume of healthcare tasks and Jevons paradox in medical demand.43:12–47:30 · Harry as informed peer 4/10 Inference Demand and Token Consumption Growth Harry brings up Goldman Sachs token consumption research and explores executive hiring challenges. Shiv shares an anecdote about an late-night call from Jensen Huang on finding joy in all aspects of leadership.47:30–50:48 · Harry as informed peer 4/10 CEO Strengths, Weaknesses, and the Reality of HR Harry challenges remote work and HR functions, citing pushback from his own tweets. Shiv defends a balanced 3-day in-office policy and delegating culture-carrying responsibilities to trusted executives as the company grows to 450 people.50:48–53:21 · Harry as informed peer 4/10 Defining Abridge's Culture: The Hiring Fire Harry shares his 'Titanic rule' on response times and asks if Shiv is a wartime CEO. Shiv insists all high-growth startup CEOs must operate in wartime mode in fast-evolving markets.53:21–55:27 · Harry as informed peer 4/10 The Most Challenging Chapters of Growth Harry asks how Shiv prevents loose spending after raising a massive $300M round. Shiv explains hiring principled finance leaders who maintain discipline while spending aggressively where it creates winning leverage.55:27–57:39 · Harry as informed peer 5/10 Navigating the Toughest Funding Round: The Series A-1 Harry candidly reacts to Abridge having a 'Series A-1' round and probes the power transition between VCs and founders when a company becomes a fund-returner. Shiv explains navigating pre-inflection fundraising with supportive insiders.57:39–1:00:33 · Harry as informed peer 3/10 CEO Parenting and Personal Non-Negotiables Harry and Shiv trade personal non-negotiables regarding family time while running high-demand careers. Shiv discusses accepting the explicit trade-offs of founder life while prioritizing weekly visits with his parents in Pittsburgh.1:00:33–1:05:11 · Harry as informed peer 5/10 The Case for San Francisco and its AI Hub Advantage Harry explicitly challenges Shiv by stating San Francisco is the worst place to start a company due to intense talent competition. Shiv firmly rejects this premise, arguing that SF's sheer concentration of AI talent and osmotic learning make it an unmatched hub.1:05:11–1:08:02 · Harry as informed peer 3/10 Quick-Fire Round: Costco's Culture and the Reimagined Healthcare Business Model In the quick-fire round, Harry asks rapid questions on organizational flattening, favorite investors, and underappreciated CEOs. Shiv highlights Costco's CEO and explains how AI will fundamentally rewrite healthcare business models over the next 3-5 years.1:09–3:31 · Guest teaching 1/10 Meeting and Early Impressions Harry opens with warm praise and an engaging binary question on founder motivation before asking about market timing lessons. Shiv responds collaboratively, reflecting on maintaining thesis resilience during Abridge's early wilderness period.3:31–6:42 · Guest teaching 2/10 Dying on the Hill: Unwavering Commitment to the Core Thesis Harry challenges whether Shiv would have died on his thesis if the market hadn't caught up, pressing on early fundraising difficulties. Shiv articulates how he pivoted tactics while holding firm to his core thesis on healthcare conversations.6:42–9:45 · Guest teaching 2/10 The Differentiator of Taste in the Era of AI Harry brings up taste as a human differentiator in AI, asking Shiv to reflect on company values and strong opinions loosely held. Shiv explains living at the edge of culture and updating priors as company scope expands.9:45–13:36 · Guest teaching 4/10 Ambition and the Impossibility of Founder Satisfaction Harry uses his experience as an investor in Legora to frame questions about market adoption and GTM traps in enterprise healthcare. Shiv educates Harry on the fragmented $5.3T healthcare market structure and timing the move upmarket.13:36–17:39 · Guest teaching 4/10 The Timing of Being First and the Three Eras of AI-Native Companies Harry asks how vertical AI companies survive foundation models building healthcare apps. Shiv responds forcefully that fighting foundation models is a losing battle and outlines Abridge's deep workflow integration and mid/post-training strategy.17:39–19:44 · Guest teaching 4/10 Proprietary Models vs. Riding the Frontier Model Wave Harry pushes back on the decision to build in-house models given historical precedents like Cursor and fast-moving foundation models. Shiv explains that in-house models are necessary to optimize latency, cost, and workflow speed for doctors.19:44–23:53 · Guest teaching 3/10 Optimizing for Milliseconds and User Experience Harry challenges Shiv on when cost consciousness becomes essential for funded startups, bringing up IPO timing. Shiv recounts a conversation with Henry Kravis to explain why serving the mission in private markets takes precedence over premature optimization.23:53–27:09 · Guest teaching 4/10 Data Cleanliness, Deployment Complexities, and the FDE Process Harry questions whether an FDE model is mandatory for selling AI into enterprise healthcare. Shiv details how Abridge picked a universal spoken wedge (doctor-patient notes) to scale without needing massive forward deployment teams.27:09–30:29 · Guest teaching 4/10 Moving Closer to the Flow of Money and Threading the Stakeholder Needle Harry pushes Shiv with feedback from an anonymous investor regarding moving closer to money flows, and asks how they compete with entrenched players like Epic. Shiv reframes Epic as a partner EMR while Abridge operates as the intelligence layer.30:29–33:21 · Guest teaching 3/10 Reflecting on Missteps: The Pivot from Patient-Facing to Enterprise Harry directly probes whether building a consumer-facing app during the pandemic was a strategic mistake. Shiv acknowledges spending too many cycles on DTC monetization before shifting focus to enterprise healthcare revenue.33:21–36:17 · Guest teaching 3/10 Pricing Models and Competing with Microsoft Nuance Harry asks how Abridge handles pricing mechanics against CFO expectations and bundling threats from Microsoft Nuance. Shiv describes counter-positioning against Microsoft's complex pricing structures and building category dominance.36:17–39:42 · Guest teaching 4/10 Focus, Counter-Positioning, and Competing with Giants Harry presents a strong counterargument, asking if withholding healthcare data from frontier models like OpenAI is actually immoral given potential public health benefits. Shiv counters that trust and explicit health-system alignment are prerequisite to long-term impact.39:42–43:12 · Guest teaching 5/10 Talent Acquisition: Prioritizing People Over Early Model Access Harry provocatively suggests that if AI is giving doctors prompts and diagnoses, AI should just replace them. Shiv firmly pushes back, explaining the sheer volume of healthcare tasks and Jevons paradox in medical demand.43:12–47:30 · Guest teaching 3/10 Inference Demand and Token Consumption Growth Harry brings up Goldman Sachs token consumption research and explores executive hiring challenges. Shiv shares an anecdote about an late-night call from Jensen Huang on finding joy in all aspects of leadership.47:30–50:48 · Guest teaching 2/10 CEO Strengths, Weaknesses, and the Reality of HR Harry challenges remote work and HR functions, citing pushback from his own tweets. Shiv defends a balanced 3-day in-office policy and delegating culture-carrying responsibilities to trusted executives as the company grows to 450 people.50:48–53:21 · Guest teaching 2/10 Defining Abridge's Culture: The Hiring Fire Harry shares his 'Titanic rule' on response times and asks if Shiv is a wartime CEO. Shiv insists all high-growth startup CEOs must operate in wartime mode in fast-evolving markets.53:21–55:27 · Guest teaching 3/10 The Most Challenging Chapters of Growth Harry asks how Shiv prevents loose spending after raising a massive $300M round. Shiv explains hiring principled finance leaders who maintain discipline while spending aggressively where it creates winning leverage.55:27–57:39 · Guest teaching 3/10 Navigating the Toughest Funding Round: The Series A-1 Harry candidly reacts to Abridge having a 'Series A-1' round and probes the power transition between VCs and founders when a company becomes a fund-returner. Shiv explains navigating pre-inflection fundraising with supportive insiders.57:39–1:00:33 · Guest teaching 2/10 CEO Parenting and Personal Non-Negotiables Harry and Shiv trade personal non-negotiables regarding family time while running high-demand careers. Shiv discusses accepting the explicit trade-offs of founder life while prioritizing weekly visits with his parents in Pittsburgh.1:00:33–1:05:11 · Guest teaching 4/10 The Case for San Francisco and its AI Hub Advantage Harry explicitly challenges Shiv by stating San Francisco is the worst place to start a company due to intense talent competition. Shiv firmly rejects this premise, arguing that SF's sheer concentration of AI talent and osmotic learning make it an unmatched hub.1:05:11–1:08:02 · Guest teaching 2/10 Quick-Fire Round: Costco's Culture and the Reimagined Healthcare Business Model In the quick-fire round, Harry asks rapid questions on organizational flattening, favorite investors, and underappreciated CEOs. Shiv highlights Costco's CEO and explains how AI will fundamentally rewrite healthcare business models over the next 3-5 years.1:09–3:31 · Guest disagreement 0/10 Meeting and Early Impressions Harry opens with warm praise and an engaging binary question on founder motivation before asking about market timing lessons. Shiv responds collaboratively, reflecting on maintaining thesis resilience during Abridge's early wilderness period.3:31–6:42 · Guest disagreement 1/10 Dying on the Hill: Unwavering Commitment to the Core Thesis Harry challenges whether Shiv would have died on his thesis if the market hadn't caught up, pressing on early fundraising difficulties. Shiv articulates how he pivoted tactics while holding firm to his core thesis on healthcare conversations.6:42–9:45 · Guest disagreement 0/10 The Differentiator of Taste in the Era of AI Harry brings up taste as a human differentiator in AI, asking Shiv to reflect on company values and strong opinions loosely held. Shiv explains living at the edge of culture and updating priors as company scope expands.9:45–13:36 · Guest disagreement 1/10 Ambition and the Impossibility of Founder Satisfaction Harry uses his experience as an investor in Legora to frame questions about market adoption and GTM traps in enterprise healthcare. Shiv educates Harry on the fragmented $5.3T healthcare market structure and timing the move upmarket.13:36–17:39 · Guest disagreement 2/10 The Timing of Being First and the Three Eras of AI-Native Companies Harry asks how vertical AI companies survive foundation models building healthcare apps. Shiv responds forcefully that fighting foundation models is a losing battle and outlines Abridge's deep workflow integration and mid/post-training strategy.17:39–19:44 · Guest disagreement 2/10 Proprietary Models vs. Riding the Frontier Model Wave Harry pushes back on the decision to build in-house models given historical precedents like Cursor and fast-moving foundation models. Shiv explains that in-house models are necessary to optimize latency, cost, and workflow speed for doctors.19:44–23:53 · Guest disagreement 1/10 Optimizing for Milliseconds and User Experience Harry challenges Shiv on when cost consciousness becomes essential for funded startups, bringing up IPO timing. Shiv recounts a conversation with Henry Kravis to explain why serving the mission in private markets takes precedence over premature optimization.23:53–27:09 · Guest disagreement 1/10 Data Cleanliness, Deployment Complexities, and the FDE Process Harry questions whether an FDE model is mandatory for selling AI into enterprise healthcare. Shiv details how Abridge picked a universal spoken wedge (doctor-patient notes) to scale without needing massive forward deployment teams.27:09–30:29 · Guest disagreement 2/10 Moving Closer to the Flow of Money and Threading the Stakeholder Needle Harry pushes Shiv with feedback from an anonymous investor regarding moving closer to money flows, and asks how they compete with entrenched players like Epic. Shiv reframes Epic as a partner EMR while Abridge operates as the intelligence layer.30:29–33:21 · Guest disagreement 1/10 Reflecting on Missteps: The Pivot from Patient-Facing to Enterprise Harry directly probes whether building a consumer-facing app during the pandemic was a strategic mistake. Shiv acknowledges spending too many cycles on DTC monetization before shifting focus to enterprise healthcare revenue.33:21–36:17 · Guest disagreement 1/10 Pricing Models and Competing with Microsoft Nuance Harry asks how Abridge handles pricing mechanics against CFO expectations and bundling threats from Microsoft Nuance. Shiv describes counter-positioning against Microsoft's complex pricing structures and building category dominance.36:17–39:42 · Guest disagreement 3/10 Focus, Counter-Positioning, and Competing with Giants Harry presents a strong counterargument, asking if withholding healthcare data from frontier models like OpenAI is actually immoral given potential public health benefits. Shiv counters that trust and explicit health-system alignment are prerequisite to long-term impact.39:42–43:12 · Guest disagreement 3/10 Talent Acquisition: Prioritizing People Over Early Model Access Harry provocatively suggests that if AI is giving doctors prompts and diagnoses, AI should just replace them. Shiv firmly pushes back, explaining the sheer volume of healthcare tasks and Jevons paradox in medical demand.43:12–47:30 · Guest disagreement 0/10 Inference Demand and Token Consumption Growth Harry brings up Goldman Sachs token consumption research and explores executive hiring challenges. Shiv shares an anecdote about an late-night call from Jensen Huang on finding joy in all aspects of leadership.47:30–50:48 · Guest disagreement 2/10 CEO Strengths, Weaknesses, and the Reality of HR Harry challenges remote work and HR functions, citing pushback from his own tweets. Shiv defends a balanced 3-day in-office policy and delegating culture-carrying responsibilities to trusted executives as the company grows to 450 people.50:48–53:21 · Guest disagreement 2/10 Defining Abridge's Culture: The Hiring Fire Harry shares his 'Titanic rule' on response times and asks if Shiv is a wartime CEO. Shiv insists all high-growth startup CEOs must operate in wartime mode in fast-evolving markets.53:21–55:27 · Guest disagreement 1/10 The Most Challenging Chapters of Growth Harry asks how Shiv prevents loose spending after raising a massive $300M round. Shiv explains hiring principled finance leaders who maintain discipline while spending aggressively where it creates winning leverage.55:27–57:39 · Guest disagreement 2/10 Navigating the Toughest Funding Round: The Series A-1 Harry candidly reacts to Abridge having a 'Series A-1' round and probes the power transition between VCs and founders when a company becomes a fund-returner. Shiv explains navigating pre-inflection fundraising with supportive insiders.57:39–1:00:33 · Guest disagreement 0/10 CEO Parenting and Personal Non-Negotiables Harry and Shiv trade personal non-negotiables regarding family time while running high-demand careers. Shiv discusses accepting the explicit trade-offs of founder life while prioritizing weekly visits with his parents in Pittsburgh.1:00:33–1:05:11 · Guest disagreement 4/10 The Case for San Francisco and its AI Hub Advantage Harry explicitly challenges Shiv by stating San Francisco is the worst place to start a company due to intense talent competition. Shiv firmly rejects this premise, arguing that SF's sheer concentration of AI talent and osmotic learning make it an unmatched hub.1:05:11–1:08:02 · Guest disagreement 1/10 Quick-Fire Round: Costco's Culture and the Reimagined Healthcare Business Model In the quick-fire round, Harry asks rapid questions on organizational flattening, favorite investors, and underappreciated CEOs. Shiv highlights Costco's CEO and explains how AI will fundamentally rewrite healthcare business models over the next 3-5 years.1:09–3:31 · Harry pushing back 0/10 Meeting and Early Impressions Harry opens with warm praise and an engaging binary question on founder motivation before asking about market timing lessons. Shiv responds collaboratively, reflecting on maintaining thesis resilience during Abridge's early wilderness period.3:31–6:42 · Harry pushing back 2/10 Dying on the Hill: Unwavering Commitment to the Core Thesis Harry challenges whether Shiv would have died on his thesis if the market hadn't caught up, pressing on early fundraising difficulties. Shiv articulates how he pivoted tactics while holding firm to his core thesis on healthcare conversations.6:42–9:45 · Harry pushing back 1/10 The Differentiator of Taste in the Era of AI Harry brings up taste as a human differentiator in AI, asking Shiv to reflect on company values and strong opinions loosely held. Shiv explains living at the edge of culture and updating priors as company scope expands.9:45–13:36 · Harry pushing back 2/10 Ambition and the Impossibility of Founder Satisfaction Harry uses his experience as an investor in Legora to frame questions about market adoption and GTM traps in enterprise healthcare. Shiv educates Harry on the fragmented $5.3T healthcare market structure and timing the move upmarket.13:36–17:39 · Harry pushing back 3/10 The Timing of Being First and the Three Eras of AI-Native Companies Harry asks how vertical AI companies survive foundation models building healthcare apps. Shiv responds forcefully that fighting foundation models is a losing battle and outlines Abridge's deep workflow integration and mid/post-training strategy.17:39–19:44 · Harry pushing back 4/10 Proprietary Models vs. Riding the Frontier Model Wave Harry pushes back on the decision to build in-house models given historical precedents like Cursor and fast-moving foundation models. Shiv explains that in-house models are necessary to optimize latency, cost, and workflow speed for doctors.19:44–23:53 · Harry pushing back 3/10 Optimizing for Milliseconds and User Experience Harry challenges Shiv on when cost consciousness becomes essential for funded startups, bringing up IPO timing. Shiv recounts a conversation with Henry Kravis to explain why serving the mission in private markets takes precedence over premature optimization.23:53–27:09 · Harry pushing back 2/10 Data Cleanliness, Deployment Complexities, and the FDE Process Harry questions whether an FDE model is mandatory for selling AI into enterprise healthcare. Shiv details how Abridge picked a universal spoken wedge (doctor-patient notes) to scale without needing massive forward deployment teams.27:09–30:29 · Harry pushing back 4/10 Moving Closer to the Flow of Money and Threading the Stakeholder Needle Harry pushes Shiv with feedback from an anonymous investor regarding moving closer to money flows, and asks how they compete with entrenched players like Epic. Shiv reframes Epic as a partner EMR while Abridge operates as the intelligence layer.30:29–33:21 · Harry pushing back 3/10 Reflecting on Missteps: The Pivot from Patient-Facing to Enterprise Harry directly probes whether building a consumer-facing app during the pandemic was a strategic mistake. Shiv acknowledges spending too many cycles on DTC monetization before shifting focus to enterprise healthcare revenue.33:21–36:17 · Harry pushing back 3/10 Pricing Models and Competing with Microsoft Nuance Harry asks how Abridge handles pricing mechanics against CFO expectations and bundling threats from Microsoft Nuance. Shiv describes counter-positioning against Microsoft's complex pricing structures and building category dominance.36:17–39:42 · Harry pushing back 5/10 Focus, Counter-Positioning, and Competing with Giants Harry presents a strong counterargument, asking if withholding healthcare data from frontier models like OpenAI is actually immoral given potential public health benefits. Shiv counters that trust and explicit health-system alignment are prerequisite to long-term impact.39:42–43:12 · Harry pushing back 5/10 Talent Acquisition: Prioritizing People Over Early Model Access Harry provocatively suggests that if AI is giving doctors prompts and diagnoses, AI should just replace them. Shiv firmly pushes back, explaining the sheer volume of healthcare tasks and Jevons paradox in medical demand.43:12–47:30 · Harry pushing back 2/10 Inference Demand and Token Consumption Growth Harry brings up Goldman Sachs token consumption research and explores executive hiring challenges. Shiv shares an anecdote about an late-night call from Jensen Huang on finding joy in all aspects of leadership.47:30–50:48 · Harry pushing back 3/10 CEO Strengths, Weaknesses, and the Reality of HR Harry challenges remote work and HR functions, citing pushback from his own tweets. Shiv defends a balanced 3-day in-office policy and delegating culture-carrying responsibilities to trusted executives as the company grows to 450 people.50:48–53:21 · Harry pushing back 3/10 Defining Abridge's Culture: The Hiring Fire Harry shares his 'Titanic rule' on response times and asks if Shiv is a wartime CEO. Shiv insists all high-growth startup CEOs must operate in wartime mode in fast-evolving markets.53:21–55:27 · Harry pushing back 3/10 The Most Challenging Chapters of Growth Harry asks how Shiv prevents loose spending after raising a massive $300M round. Shiv explains hiring principled finance leaders who maintain discipline while spending aggressively where it creates winning leverage.55:27–57:39 · Harry pushing back 4/10 Navigating the Toughest Funding Round: The Series A-1 Harry candidly reacts to Abridge having a 'Series A-1' round and probes the power transition between VCs and founders when a company becomes a fund-returner. Shiv explains navigating pre-inflection fundraising with supportive insiders.57:39–1:00:33 · Harry pushing back 1/10 CEO Parenting and Personal Non-Negotiables Harry and Shiv trade personal non-negotiables regarding family time while running high-demand careers. Shiv discusses accepting the explicit trade-offs of founder life while prioritizing weekly visits with his parents in Pittsburgh.1:00:33–1:05:11 · Harry pushing back 5/10 The Case for San Francisco and its AI Hub Advantage Harry explicitly challenges Shiv by stating San Francisco is the worst place to start a company due to intense talent competition. Shiv firmly rejects this premise, arguing that SF's sheer concentration of AI talent and osmotic learning make it an unmatched hub.1:05:11–1:08:02 · Harry pushing back 1/10 Quick-Fire Round: Costco's Culture and the Reimagined Healthcare Business Model In the quick-fire round, Harry asks rapid questions on organizational flattening, favorite investors, and underappreciated CEOs. Shiv highlights Costco's CEO and explains how AI will fundamentally rewrite healthcare business models over the next 3-5 years.

speaking balance: gold is Harry, purple is the guest (3 minute bins)

0:00 · Harry 55.8% · guest 44.2%0:00 · Harry 55.8% · guest 44.2%3:00 · Harry 20.7% · guest 79.3%3:00 · Harry 20.7% · guest 79.3%6:00 · Harry 19% · guest 81%6:00 · Harry 19% · guest 81%9:00 · Harry 20.1% · guest 79.9%9:00 · Harry 20.1% · guest 79.9%12:00 · Harry 5.6% · guest 94.4%12:00 · Harry 5.6% · guest 94.4%15:00 · Harry 18.1% · guest 81.9%15:00 · Harry 18.1% · guest 81.9%18:00 · Harry 10.4% · guest 89.6%18:00 · Harry 10.4% · guest 89.6%21:00 · Harry 25% · guest 75%21:00 · Harry 25% · guest 75%24:00 · Harry 9.5% · guest 90.5%24:00 · Harry 9.5% · guest 90.5%27:00 · Harry 19.4% · guest 80.6%27:00 · Harry 19.4% · guest 80.6%30:00 · Harry 8.2% · guest 91.8%30:00 · Harry 8.2% · guest 91.8%33:00 · Harry 27.2% · guest 72.8%33:00 · Harry 27.2% · guest 72.8%36:00 · Harry 34.3% · guest 65.7%36:00 · Harry 34.3% · guest 65.7%39:00 · Harry 14.6% · guest 85.4%39:00 · Harry 14.6% · guest 85.4%42:00 · Harry 26.4% · guest 73.6%42:00 · Harry 26.4% · guest 73.6%45:00 · Harry 14.8% · guest 85.2%45:00 · Harry 14.8% · guest 85.2%48:00 · Harry 39% · guest 61%48:00 · Harry 39% · guest 61%51:00 · Harry 30.4% · guest 69.6%51:00 · Harry 30.4% · guest 69.6%54:00 · Harry 30% · guest 70%54:00 · Harry 30% · guest 70%57:00 · Harry 28.3% · guest 71.7%57:00 · Harry 28.3% · guest 71.7%1:00:00 · Harry 23.6% · guest 76.4%1:00:00 · Harry 23.6% · guest 76.4%1:03:00 · Harry 10.9% · guest 89.1%1:03:00 · Harry 10.9% · guest 89.1%1:06:00 · Harry 9.2% · guest 90.8%1:06:00 · Harry 9.2% · guest 90.8%
Sharpest disagreement ▶ 1:00:53 Premise rejection on San Francisco as a startup location

Shiv flatly rejects Harry's assertion that San Francisco is the worst place to start an AI company, arguing that the concentration of early-stage talent and osmotic energy in SF is unmatched.

Hardest push from Harry ▶ 41:28 Refusing framing on AI replacing doctors

Harry pushes back forcefully when Shiv describes AI suggesting diagnoses, arguing that if AI can provide diagnostic prompts, it should simply replace the doctor entirely.

Biggest teaching moment ▶ 11:26 Healthcare market segmentation masterclass

Shiv educates Harry on the structural nuance of the $5.3T US healthcare industry, explaining why staying downmarket is a trap and detailing how practicing physicians are concentrated across specific enterprise care systems.

Harry holds his own ▶ 38:19 Moral framing counterargument on healthcare data

Harry uses his domain expertise to challenge Shiv's refusal to monetize data, arguing that withholding patient data from frontier models presents an ethical dilemma by slowing down global healthcare advancement.

the scores for every segment, with the reasoning behind each
ChapterTopicHarry as informed peerGuest teachingGuest disagreementHarry pushing backWhy
Meeting and Early Impressions 2100 Harry opens with warm praise and an engaging binary question on founder motivation before asking about market timing lessons. Shiv responds collaboratively, reflecting on maintaining thesis resilience during Abridge's early wilderness period.
Dying on the Hill: Unwavering Commitment to the Core Thesis 3212 Harry challenges whether Shiv would have died on his thesis if the market hadn't caught up, pressing on early fundraising difficulties. Shiv articulates how he pivoted tactics while holding firm to his core thesis on healthcare conversations.
The Differentiator of Taste in the Era of AI 2201 Harry brings up taste as a human differentiator in AI, asking Shiv to reflect on company values and strong opinions loosely held. Shiv explains living at the edge of culture and updating priors as company scope expands.
Ambition and the Impossibility of Founder Satisfaction 4412 Harry uses his experience as an investor in Legora to frame questions about market adoption and GTM traps in enterprise healthcare. Shiv educates Harry on the fragmented $5.3T healthcare market structure and timing the move upmarket.
The Timing of Being First and the Three Eras of AI-Native Companies 5423 Harry asks how vertical AI companies survive foundation models building healthcare apps. Shiv responds forcefully that fighting foundation models is a losing battle and outlines Abridge's deep workflow integration and mid/post-training strategy.
Proprietary Models vs. Riding the Frontier Model Wave 5424 Harry pushes back on the decision to build in-house models given historical precedents like Cursor and fast-moving foundation models. Shiv explains that in-house models are necessary to optimize latency, cost, and workflow speed for doctors.
Optimizing for Milliseconds and User Experience 4313 Harry challenges Shiv on when cost consciousness becomes essential for funded startups, bringing up IPO timing. Shiv recounts a conversation with Henry Kravis to explain why serving the mission in private markets takes precedence over premature optimization.
Data Cleanliness, Deployment Complexities, and the FDE Process 4412 Harry questions whether an FDE model is mandatory for selling AI into enterprise healthcare. Shiv details how Abridge picked a universal spoken wedge (doctor-patient notes) to scale without needing massive forward deployment teams.
Moving Closer to the Flow of Money and Threading the Stakeholder Needle 5424 Harry pushes Shiv with feedback from an anonymous investor regarding moving closer to money flows, and asks how they compete with entrenched players like Epic. Shiv reframes Epic as a partner EMR while Abridge operates as the intelligence layer.
Reflecting on Missteps: The Pivot from Patient-Facing to Enterprise 4313 Harry directly probes whether building a consumer-facing app during the pandemic was a strategic mistake. Shiv acknowledges spending too many cycles on DTC monetization before shifting focus to enterprise healthcare revenue.
Pricing Models and Competing with Microsoft Nuance 4313 Harry asks how Abridge handles pricing mechanics against CFO expectations and bundling threats from Microsoft Nuance. Shiv describes counter-positioning against Microsoft's complex pricing structures and building category dominance.
Focus, Counter-Positioning, and Competing with Giants 5435 Harry presents a strong counterargument, asking if withholding healthcare data from frontier models like OpenAI is actually immoral given potential public health benefits. Shiv counters that trust and explicit health-system alignment are prerequisite to long-term impact.
Talent Acquisition: Prioritizing People Over Early Model Access 5535 Harry provocatively suggests that if AI is giving doctors prompts and diagnoses, AI should just replace them. Shiv firmly pushes back, explaining the sheer volume of healthcare tasks and Jevons paradox in medical demand.
Inference Demand and Token Consumption Growth 4302 Harry brings up Goldman Sachs token consumption research and explores executive hiring challenges. Shiv shares an anecdote about an late-night call from Jensen Huang on finding joy in all aspects of leadership.
CEO Strengths, Weaknesses, and the Reality of HR 4223 Harry challenges remote work and HR functions, citing pushback from his own tweets. Shiv defends a balanced 3-day in-office policy and delegating culture-carrying responsibilities to trusted executives as the company grows to 450 people.
Defining Abridge's Culture: The Hiring Fire 4223 Harry shares his 'Titanic rule' on response times and asks if Shiv is a wartime CEO. Shiv insists all high-growth startup CEOs must operate in wartime mode in fast-evolving markets.
The Most Challenging Chapters of Growth 4313 Harry asks how Shiv prevents loose spending after raising a massive $300M round. Shiv explains hiring principled finance leaders who maintain discipline while spending aggressively where it creates winning leverage.
Navigating the Toughest Funding Round: The Series A-1 5324 Harry candidly reacts to Abridge having a 'Series A-1' round and probes the power transition between VCs and founders when a company becomes a fund-returner. Shiv explains navigating pre-inflection fundraising with supportive insiders.
CEO Parenting and Personal Non-Negotiables 3201 Harry and Shiv trade personal non-negotiables regarding family time while running high-demand careers. Shiv discusses accepting the explicit trade-offs of founder life while prioritizing weekly visits with his parents in Pittsburgh.
The Case for San Francisco and its AI Hub Advantage 5445 Harry explicitly challenges Shiv by stating San Francisco is the worst place to start a company due to intense talent competition. Shiv firmly rejects this premise, arguing that SF's sheer concentration of AI talent and osmotic learning make it an unmatched hub.
Quick-Fire Round: Costco's Culture and the Reimagined Healthcare Business Model 3211 In the quick-fire round, Harry asks rapid questions on organizational flattening, favorite investors, and underappreciated CEOs. Shiv highlights Costco's CEO and explains how AI will fundamentally rewrite healthcare business models over the next 3-5 years.

Statements from this episode (60)

Prediction Not checkable as stated
Healthcare system is unprepared for an impending surge in needs
“We're in for a tsunami of healthcare needs and the system is not prepared to deliver it.”
Shiv Rao May 16, 2026 ▶ 43:05
Insight
Great CEOs are driven by fear of losing or thrill of winning
“Great CEOs are motivated by one of two things I found. Either the fear of losing, or the thrill of winning.”
Harry Stebbings May 16, 2026 ▶ 1:39
Insight
Clinical conversations can power new healthcare AI infrastructure
“It was this thesis that this idea, the secret hiding in plain sight, that this data set, this, like these conversations, it's the most human signal and it really powers healthcare. And you can build a whole new set of rails on top of this signal.”
Shiv Rao May 16, 2026 ▶ 3:11
Disclosure
Abridge raised a $5M seed round at a $15M pre-money valuation
“Our series seed was like, we raised five million dollars on a pre of 15.”
Shiv Rao May 16, 2026 ▶ 4:57
Assertion Not checkable as stated
Doctors refuse to join hospital networks that do not provide Abridge
“There are doctors right now who we've heard who won't sign up to join a healthcare system, a hospital, if they don't have a bridge.”
Shiv Rao May 16, 2026 ▶ 10:58
Assertion Supported
800,000 US doctors actively practice, mostly in large delivery systems
“There's about a million doctors in the country, maybe 800,000 of them are actually practicing. The vast majority of them are concentrated in large care delivery systems.”
Shiv Rao May 16, 2026 ▶ 11:59
Insight
Healthcare founders trap themselves by staying down-market too long
“The trap that a lot of, I think healthcare founders fall into is that they stay down market. They don't figure out, they don't like Time their Yolo shot to go up market at the right moment.”
Shiv Rao May 16, 2026 ▶ 12:35
Assertion Partly supported
JAMA study showed 30% of US nurses planned to leave profession
“There was a study about nurses recently that was published in JAMA that suggested that 30% of nurses in the country Didn't want to be nurses in the next 12 months.”
Shiv Rao May 16, 2026 ▶ 13:05
Assertion Partly supported
Abridge was founded three months after the Transformer paper
“We started three months after the Transformer paper.”
Shiv Rao May 16, 2026 ▶ 14:10
Insight
Vertical AI startups cannot win by fighting foundation model labs
“If you are fighting against them, you've already lost. If you haven't figured out how you're going to win with them, how you're gonna not just coexist, but actually find ways to collaborate potentially, and if the tailwinds that they create are not yours to le…”
Shiv Rao May 16, 2026 ▶ 15:28
Assertion Supported
US healthcare sector is $5.3T and 18-19% of GDP
“Healthcare, 5.3 trillion dollar, you know, market. It's about 18, 19% of US GDP.”
Shiv Rao May 16, 2026 ▶ 15:50
Insight
Highest-upside vertical AI companies control full tech stack
“I think the vertical AI companies that have the most leverage that have the most upside are the ones that can reach farther down into the stack and own their destiny in a different differentiated way that can kind of control their P and L.”
Shiv Rao May 16, 2026 ▶ 17:22
Disclosure
Forty percent of Abridge's model outputs come from in-house models
“About 40% of our model outputs inside our product are generated by in-house models.”
Shiv Rao May 16, 2026 ▶ 17:45
Insight
Use frontier AI models when building features that require endless improvement
“If the market cares about you always improving on something that you don't think you'll ever be perfect on, and healthcare has a lot of use cases like this, it makes more sense to ride the frontier wave.”
Shiv Rao May 16, 2026 ▶ 19:34
Disclosure
Frontier models could not meet latency needs for key healthcare workflows
“But that kind of experience you need insane performance and latency And that's something that we weren't able to achieve in an easy, elegant way with Frontier model. So for certain use cases, there was really no choice.”
Shiv Rao May 16, 2026 ▶ 20:41
Disclosure
Henry Kravis is an investor in Abridge
“One of our investors is Henry Kravis”
Shiv Rao May 16, 2026 ▶ 23:02
Prediction Not checkable as stated
Abridge will remain private as long as private capital supports its mission
“I have a mission, and to serve that mission I will do what it takes, and if I can do it in the private markets, I'll raise money there. If I need to go public to do that, then I will go public.”
Shiv Rao May 16, 2026 ▶ 23:43
Prediction Not checkable as stated
Data cleanliness will be AI's biggest enterprise barrier
“I think one of the biggest barriers to AI progression within large enterprise in the next few years will be data cleanliness, data structure within large enterprises.”
Harry Stebbings May 16, 2026 ▶ 23:53
Opinion
Healthcare AI startups do not need forward-deployed engineers
“No, you don't. Not in our case. You're going to get to that zero to one. You're going to get to that first product in all the ways, like people in, you know, in the health systems, in the clinics and listening to the doctors and the nurses and figuring it out.…”
Shiv Rao May 16, 2026 ▶ 25:21
Assertion Supported
Doctors are compensated for documented care, not care delivered
“So when you think about it in, in the United States, but really this is like true in many parts of the world, clinicians, doctors, they're not compensated for the care that they deliver. They're compensated for the care that they documented, that they deliver.”
Shiv Rao May 16, 2026 ▶ 27:32
Insight
Winning healthcare enterprise sales requires aligning CMIO, CIO, and CFO
“And so you got to take that responsibility very seriously because the enterprise motion in healthcare is complicated. You have a lot of different stakeholders. You have your end users, but then you have the decision makers and there's a CMIO, chief medical inf…”
Shiv Rao May 16, 2026 ▶ 27:59
Opinion
Epic is an entrenched EMR product that nobody likes
“They're like the product that no one likes, but it's so entrenched. Like, so entrenched.”
Harry Stebbings May 16, 2026 ▶ 28:54
Prediction Open · timeframe May 2031
Abridge will never become an electronic medical record system
“Like we don't ever want to be an electronic medical record.”
Shiv Rao May 16, 2026 ▶ 29:40
Opinion
Epic was the best EMR software during clinical practice
“And I was at a health system that had multiple medical records, and I was always the happiest when I was using Epic compared to any others out there.”
Shiv Rao May 16, 2026 ▶ 29:53
Prediction Held up
Abridge is expanding back into patient-facing healthcare software
“Actually, we're getting back to the patient side of that slide now, again,”
Shiv Rao May 16, 2026 ▶ 32:04
Insight
Consumer-only healthcare startups rely on untrustworthy data-selling models
“The companies that you can build on top of just the consumer and healthcare, Oftentimes there's the kind of companies that, that paint themselves into a corner that can never be trustworthy enough to go enterprise. They're the kind of companies where the busin…”
Shiv Rao May 16, 2026 ▶ 32:30
Assertion Supported
Microsoft bought Nuance for $20B+ and competed with Abridge
“And the first big competitor for us was Microsoft. They had bought a company called Nuance for 20 some billion some years ago, and they had a product in our category and we still compete with them in the marketplace.”
Shiv Rao May 16, 2026 ▶ 34:04
Disclosure
Abridge rarely encounters competitors Nabla or Candidate in sales deals anymore
“We don't see either of those companies much anymore.”
Shiv Rao May 16, 2026 ▶ 34:51
Opinion
Microsoft obfuscates pricing and overcomplicates enterprise software
“Especially like the Microsofts of the world just obfuscate things so much and make things so complicated.”
Shiv Rao May 16, 2026 ▶ 35:56
Insight
Make a competitor's side project your primary business focus
“I always want my main course to be someone else's dessert because like I'm going to care much more than they do.”
Harry Stebbings May 16, 2026 ▶ 36:18
Disclosure
Abridge does not make money selling data
“We don't make any money selling data.”
Shiv Rao May 16, 2026 ▶ 37:43
Opinion
Top research talent is far more valuable than early model access
“B. B over A. Yeah, no question about it. No question about it, because ultimately it's always about the people, and if you've got incredible people, you're going to build your own models, your own primitives, and yes, the frontier models you're going to be abl…”
Shiv Rao May 16, 2026 ▶ 39:57
Assertion Partly supported
Internal medicine journal found doctors need 30 hours daily for tasks
“There was an American Journal of General Internal Medicine article that was published a few years ago that suggested that doctors need 30 hours a day to get all of their work done.”
Shiv Rao May 16, 2026 ▶ 41:47
Prediction Not checkable as stated
AI will progressively automate low-stakes primary care workflows
“It's those types of workflows that are, will, you know, progressively get automated till we get to some approximation of maybe the most boring variant of primary care, you know, that nobody wants to practice.”
Shiv Rao May 16, 2026 ▶ 42:37
Insight
Declining AI inference costs will drive exponentially higher token usage
“I don't know about the specific number, but I think directionally, I think so. I think that you just can't get enough of this technology once you start to use it. And even as inference costs come down, you just end up using more and more and more of it.”
Shiv Rao May 16, 2026 ▶ 44:02
Insight
Founder mode means targeted tours of duty, not micromanagement
“Founder mode is just about, to me, it's about tours of duty depending on what's on fire inside the company or like what's the most important thing and what you're best at. You just go crush. You just have to go you know, kill whatever that challenge is. And it…”
Shiv Rao May 16, 2026 ▶ 45:54
Assertion Not checkable as stated
NVIDIA CEO Jensen Huang maintains extremely fast response times to founders
“And so, and Jensen, NVIDIA is one of our investors, and Jensen told me this, he once called me at midnight, and I was like, on his way home, cold call, and I knew it was him and I picked it up, and it was awesome... He was calling me back Because of an email I…”
Shiv Rao May 16, 2026 ▶ 46:17
Opinion
Work-from-home Fridays lead to lower productivity and are ineffective
“If you want to work from home on Friday, that's okay, but just accept that bluntly you're not going to work as hard, you're going to go to Pilates at 10, and work from home Fridays is bullshit, four days a week.”
Harry Stebbings May 16, 2026 ▶ 48:19
Disclosure
Abridge operates on a three-day in-office hybrid work policy
“We have three days in office.”
Shiv Rao May 16, 2026 ▶ 48:36
Opinion
Rapidly scaling companies benefit significantly from in-person work
“Things are moving so quickly that the more time that you have in person, the better. There's no question about it.”
Shiv Rao May 16, 2026 ▶ 48:58
Disclosure
Abridge currently employs 450 people
“450.”
Shiv Rao May 16, 2026 ▶ 49:38
Disclosure
Shiv Rao stopped interviewing every candidate around 100 employees
“Oh, it's been a long time. It's been a long time. I. A hundred? Even, probably even a little bit before that, honestly. It was around then.”
Shiv Rao May 16, 2026 ▶ 49:58
Disclosure
20VC enforces a three-hour WhatsApp response rule to drive urgency
“It's three hours long. Everyone should be able to go to a cinema with their families. But if you were asked a question on what's apps like, You need to respond within three fucking hours. It drives efficiency and urgency.”
Harry Stebbings May 16, 2026 ▶ 51:07
Disclosure
An Abridge investor required Shiv Rao to undergo a psychological assessment
“We were talking about psychological assessments, I think, before we started, and how some VCs will do that, and I had one before we took money from one of our investors”
Shiv Rao May 16, 2026 ▶ 52:10
Disclosure
Harry Stebbings exits investments the minute founders step down as CEO
“The minute the founder transitions out of CEO role, I'm out.”
Harry Stebbings May 16, 2026 ▶ 53:09
Insight
Operating without pressure is the hardest stage of startup growth
“You know, honestly, like the chapter of company that, that sucks the most is like the one where you don't feel pressure.”
Shiv Rao May 16, 2026 ▶ 53:45
Assertion Supported
Abridge raised $300 million in its previous funding round
“Our last one was 300, about a year ago.”
Shiv Rao May 16, 2026 ▶ 54:23
Insight
Massive capital rounds are a brute instrument to win markets
“You raise this capital because it's a brute instrument now that is going to allow you to win. And so against certain things, you just don't want to even debate. And if you are, you're doing it wrong.”
Shiv Rao May 16, 2026 ▶ 54:59
Disclosure
Abridge's hardest funding round was its Series A-1
“The hardest round was a series A-one. You know, venture capital, you know, you obviously know it was a weak round. We were in a weak spot because there's like a digit at the end of it.”
Shiv Rao May 16, 2026 ▶ 55:30
Disclosure
Abridge raised its Series A-1 funding round at a $100M valuation
“It was on a hundred.”
Shiv Rao May 16, 2026 ▶ 56:29
Disclosure
Abridge attended approximately three investor LP meetings in 2023
“Yeah, I think in 2023, we did like three LP meetings. That's when I knew things were going well.”
Shiv Rao May 16, 2026 ▶ 57:26
Insight
Anyone who claims CEOs can have everything is lying
“There's trade-offs and there are sacrifices and the folks who say you can have everything are lying and you just have to be eyes wide open on what you're giving up.”
Shiv Rao May 16, 2026 ▶ 57:52
Disclosure
USV backed Abridge seed partly due to Duolingo precedent
“Also Union Square Ventures funded, and I'm sure that had something to do with USV being more comfortable with me, because I certainly didn't have a track record.”
Shiv Rao May 16, 2026 ▶ 59:05
Opinion
San Francisco is the worst place to start a company
“I think San Francisco is the worst place to start a company because it is so impossible to acquire and retain talent”
Harry Stebbings May 16, 2026 ▶ 1:00:35
Opinion
Being in San Francisco is super important for AI startups
“As we were inflecting, we just needed to be, you know, in that moment, and the amount of ideas that you just osmotically absorb by being there, the kind of talent that you have access to, the kind of mentorship that you have access to, I think it's super impor…”
Shiv Rao May 16, 2026 ▶ 1:01:38
Prediction Not checkable as stated
Abridge can operate as a flat company using AI tools
“And anymore, I'm in this very idealistic mode that we can be a very, very flat company in the near future. Just like less managers, like less, like a lot more ICs, super ICs taking on that much more, you know, everybody Everybody kind of with these tools able …”
Shiv Rao May 16, 2026 ▶ 1:02:07
Insight
Top VC kingmaking works via a psychological placebo effect on founders
“It's less the brand, it's more the placebo effect. It's more the psychology. It's when you feel like the more you can feel inevitable, the more you will be.”
Shiv Rao May 16, 2026 ▶ 1:03:18
Opinion
Elad Gil is the single investor Shiv Rao would choose today
“If I start a new company right now, I would call Elad. Elad Gill. We'd go big, like single GP, you know, like all of the wisdom in his head all that I've learned from him, his ability to go every stage and be incredibly valuable.”
Shiv Rao May 16, 2026 ▶ 1:04:12
Insight
Corporate development requires binary focus, not split-role employees
“How you need to have people just fully focused. It needs to be their entire job. You can't split people's, you know, brains on it. If you're gonna do it, you gotta be binary.”
Shiv Rao May 16, 2026 ▶ 1:04:59
Insight
US healthcare stakeholders are fundamentally misaligned with patients
“And that's what healthcare is in the United States. It's providers, health systems, pointing guns and getting pointed at by insurance companies. And then there's also life sciences companies. And those three stakeholders in some way, shape or form are misalign…”
Shiv Rao May 16, 2026 ▶ 1:06:49

Shorts cut from this episode

▶ Stop Fighting Foundation Models. Do This Instead. · 20VC wit (@15:27) ▶ The Cardiologist Who Built A $5.3BN AI Company · 20VC with H (@0:00)
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 1,200 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.